Global artificial intelligence (AI) in the cardiology market is anticipated to grow at an exponential CAGR of 25.3% during the forecast period (2024-2031).AI algorithms are used in various fields, including diagnostic imaging, risk prediction, arrhythmia detection, stroke management, ischemic heart disease management, cardiac function assessment, treatment planning, remote monitoring, drug discovery, and clinical research. These algorithms analyze cardiac imaging data to detect abnormalities, quantify cardiac function, and provide accurate diagnoses. It additionally helps in risk stratification, detecting and monitoring cardiac arrhythmias, assessing stroke severity, and guiding treatment strategies. AI-powered remote monitoring systems enable continuous monitoring of cardiac health parameters, facilitating early detection and timely interventions. AI technologies also accelerate drug discovery and development by analyzing large-scale biomedical data. These algorithms provide clinicians with evidence-based recommendations, aiding in clinical decision-making and improving patient care.Furthermore, the market has seen significant growth primarily owing to increased focus on R&D by both public and private organizations and growing applications. For instance,
Browse the full report description of “Artificial Intelligence (AI) in Cardiology Market Size, Share & Trends Analysis Report by Component (Software and Services) by Application(Cardiac Arrhythmias, Stroke, Ischemic Heart Disease /CAD, and Others) and by End-User (Life Science Companies, Healthcare Payers, and Healthcare Providers) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/ai-in-the-cardiology-market
In March 2024, Philips Healthcare introduced a new computed tomography system, the CT 5300, at the European Congress of Radiology, aimed at the growing cardiac coronary CT angiography market. The system features an AI detector optimized for image reconstruction, improving accuracy and reliability in diagnosing, interventional procedures, and screening complex cardiac cases.
In March 2022, Tempus, launched a multi-center study titled ‘Electrocardiogram-based Artificial Intelligence-Assisted Detection of Heart Disease’ to evaluate the impact of AI-enabled predictive tests in cardiology, focusing on identifying patients at high risk of heart disease.
In November 2022, Viz.ai launched Viz Cardio Suite, a cardiology software platform that enhances patient access to treatments by identifying specific cardiovascular diseases, alerting clinicians, and utilizing mobile ECG viewer, cardiac imaging viewer, and echocardiography software.
The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Component
o By Application
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Abbott Laboratories, GE HealthCare Technologies Inc., Siemens Healthineers Co., Koninklijke Philips N.V., Medtronic Plc, among others.
Key questions addressed by the report.
Global Artificial Intelligence (AI) in Cardiology Market Report Segment
By Component
By Application
By End-User
Global Artificial Intelligence (AI) in Cardiology Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ai-in-the-cardiology-market